| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |